Suppr超能文献

[α-2b干扰素治疗严重头面部血管瘤]

[Treatment of severe cervicofacial hemangioma with interferon alpha-2b].

作者信息

Mortureux P, Pedespan J M, Greselle J F, Devars F, Maleville J, Taïeb A

机构信息

Unité de dermatologie pédiatrique, hôpital Pellegrin-Enfants, Bordeaux, France.

出版信息

Arch Pediatr. 1995 Mar;2(3):237-40. doi: 10.1016/0929-693x(96)81134-1.

Abstract

BACKGROUND

Indications for active treatment of hemangiomas are those lesions which, by virtue of their size and site, compromise vital structures. The treatment of choice is oral or intravenous corticosteroids, but interferon alpha may represent alternative therapy.

CASE REPORT

A 15-day-old girl was admitted for congenital hypothyroidism. She had a large cervicofacial hemangioma extending to periorbital and laryngeal areas. The patient was given systemic prednisone (2 mg/kg/day) and L-thyroxin without success. An episode of acute respiratory distress a few weeks later required tracheostomy while prednisone dosage was increased to 4 mg/kg/day. This drug was not tolerated and the hemangioma was treated by particle embolization that was followed by a partial decrease in the volume of the hemangioma. A second episode of cardiorespiratory distress at 7 1/2 months of age required interferon alpha, 3 million units/m2/day, that was progressively effective. After 11 months of treatment, the hemangioma disappeared, without relapse 6 months later.

CONCLUSION

Interferon alpha is an interesting alternative therapy of infantile hemangiomas when they are resistant to steroid treatment.

摘要

背景

对血管瘤进行积极治疗的指征是那些因其大小和部位而危及重要结构的病变。治疗的首选方法是口服或静脉注射皮质类固醇,但干扰素α可能是一种替代疗法。

病例报告

一名15天大的女孩因先天性甲状腺功能减退症入院。她有一个巨大的颈面部血管瘤,延伸至眶周和喉部区域。患者接受了全身性泼尼松(2毫克/千克/天)和左甲状腺素治疗,但未成功。几周后发生的一次急性呼吸窘迫需要进行气管切开术,同时泼尼松剂量增加至4毫克/千克/天。该药物不耐受,血管瘤通过颗粒栓塞治疗,随后血管瘤体积部分减小。在7个半月大时发生的第二次心肺窘迫需要使用干扰素α,300万单位/平方米/天,逐渐显效。治疗11个月后,血管瘤消失,6个月后未复发。

结论

当婴儿血管瘤对类固醇治疗耐药时,干扰素α是一种有意义的替代疗法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验